NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Revolution Medicines, Inc.
Stanford University
Revolution Medicines, Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Heidelberg University